Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Favorable response of ADHD with giant SEP to extended-release valproate.

Miyazaki M, Ito H, Saijo T, Mori K, Kagami S, Kuroda Y.

Brain Dev. 2006 Aug;28(7):470-2. Epub 2006 Mar 22.

PMID:
16554135
[PubMed - indexed for MEDLINE]
2.

Valproate lowered the amplitude of visual and somatosensory evoked potentials in two cases of untreated juvenile myoclonic epilepsy.

Kanazawa O, Nagafuji H.

Psychiatry Clin Neurosci. 1997 Dec;51(6):425-9.

PMID:
9472131
[PubMed - indexed for MEDLINE]
3.

Somatosensory evoked potentials in attention deficit/hyperactivity disorder and tic disorder.

Miyazaki M, Fujii E, Saijo T, Mori K, Kagami S.

Clin Neurophysiol. 2007 Jun;118(6):1286-90. Epub 2007 Apr 26.

PMID:
17466583
[PubMed - indexed for MEDLINE]
4.

Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder.

Frank Y.

Clin Electroencephalogr. 1993 Jan;24(1):19-24.

PMID:
8420693
[PubMed - indexed for MEDLINE]
5.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
6.

Somatosensory functioning in children with attention deficit hyperactivity disorder.

Parush S, Sohmer H, Steinberg A, Kaitz M.

Dev Med Child Neurol. 1997 Jul;39(7):464-8.

PMID:
9285437
[PubMed - indexed for MEDLINE]
7.

Somatosensory function in boys with ADHD and tactile defensiveness.

Parush S, Sohmer H, Steinberg A, Kaitz M.

Physiol Behav. 2007 Mar 16;90(4):553-8. Epub 2007 Jan 2.

PMID:
17198716
[PubMed - indexed for MEDLINE]
8.

Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.

Kummer A, Teixeira A.

Australas Psychiatry. 2008 Dec;16(6):458-9. No abstract available.

PMID:
19034996
[PubMed - indexed for MEDLINE]
9.

Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder.

Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gómez N, Yelmo S, Ferrer M, Martínez Y, Casas M.

CNS Drugs. 2008;22(7):603-11.

PMID:
18547128
[PubMed - indexed for MEDLINE]
10.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
[PubMed - indexed for MEDLINE]
11.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
[PubMed - indexed for MEDLINE]
12.
13.

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA.

Arch Gen Psychiatry. 2007 Feb;64(2):218-24.

PMID:
17283289
[PubMed - indexed for MEDLINE]
14.

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.

Child Care Health Dev. 2006 Sep;32(5):575-83.

PMID:
16919137
[PubMed - indexed for MEDLINE]
15.

[Sustained effectiveness of osmotic-release methylphenidate: a study of 266 cases].

Fernández-Jaén A, Martín Fernández-Mayoralas D, Calleja-Pérez B, Muñoz-Jareño N.

Rev Neurol. 2009 Apr 1-15;48(7):339-45. Spanish.

PMID:
19319813
[PubMed - indexed for MEDLINE]
Free Article
16.

Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder.

Mikami AY, Cox DJ, Davis MT, Wilson HK, Merkel RL, Burket R.

J Clin Psychol Med Settings. 2009 Sep;16(3):233-42. doi: 10.1007/s10880-009-9165-8. Epub 2009 May 6.

PMID:
19418208
[PubMed - indexed for MEDLINE]
17.

Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys.

Torrioli M, Vernacotola S, Setini C, Bevilacqua F, Martinelli D, Snape M, Hutchison JA, Di Raimo FR, Tabolacci E, Neri G.

Am J Med Genet A. 2010 Jun;152A(6):1420-7. doi: 10.1002/ajmg.a.33484.

PMID:
20503316
[PubMed - indexed for MEDLINE]
18.

Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.

Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, Clark CR, Gordon E.

Biol Psychiatry. 2008 May 15;63(10):917-26. doi: 10.1016/j.biopsych.2007.11.022. Epub 2008 Feb 13.

PMID:
18272140
[PubMed - indexed for MEDLINE]
19.

A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.

Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R.

CNS Drugs. 2008;22(8):693-704.

PMID:
18601306
[PubMed - indexed for MEDLINE]
20.

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA.

J Clin Psychiatry. 2007 Jul;68(7):1109-16.

PMID:
17685750
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk